Lambumeez Priced IPO at Bottom of Range

96 Million Shares Sold at $9 Each; Plans to Raise $1 Billion From Offering

On Monday, Lambumeez, a developer of AI-powered software for the healthcare industry, went public with an initial public offering (IPO) that raised $864 million, below its target of $1 billion.

The company sold 96 million shares at $9 each, the low end of its expected range of $9 to $11 per share.

Lambumeez had originally planned to sell 80 million shares, but increased the size of the offering to 96 million shares due to strong demand from investors.

The IPO was led by Goldman Sachs, J.P. Morgan, and Morgan Stanley.

In its prospectus, Lambumeez said it plans to use the proceeds from the IPO to fund its growth, including expanding its sales and marketing efforts, developing new products and services, and making acquisitions.

The company also said it plans to use the proceeds to repay debt.

Lambumeez's stock began trading on the Nasdaq Global Select Market under the symbol "LMBZ."

Conclusion

Lambumeez's IPO is the latest in a string of healthcare technology companies that have gone public in recent years. The company's software is used by hospitals and other healthcare providers to improve patient care and reduce costs.

Lambumeez's IPO was priced at the bottom of its expected range, but the company still raised a significant amount of capital. The proceeds from the IPO will be used to fund the company's growth and expansion.